Thermo Fisher Scientific Inc.
TMO
$512.69
$4.590.90%
NYSE
| 12/31/2025 | 09/27/2025 | 06/28/2025 | 03/29/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 5.82% | 7.09% | 5.85% | 7.95% | 5.67% |
| Total Depreciation and Amortization | -10.55% | -12.82% | -13.15% | -12.00% | -8.75% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 135.77% | 94.75% | 60.49% | 52.01% | 13.32% |
| Change in Net Operating Assets | -377.04% | -321.47% | -314.77% | -586.60% | 29.42% |
| Cash from Operations | -9.80% | -15.92% | -18.93% | -8.84% | 3.10% |
| Capital Expenditure | -8.93% | -16.23% | -1.66% | -3.44% | 5.34% |
| Sale of Property, Plant, and Equipment | -22.81% | -33.33% | -48.45% | -23.53% | -34.48% |
| Cash Acquisitions | -28.90% | -28.90% | -244.55% | -227.62% | 14.43% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 207.69% | 134.13% | 107.12% | 108.04% | -1,417.78% |
| Cash from Investing | 30.71% | 21.15% | -13.88% | -7.64% | -13.59% |
| Total Debt Issued | 635.38% | 6.93% | -60.26% | -63.32% | -84.08% |
| Total Debt Repaid | 2.77% | 3.42% | 0.83% | 38.21% | 53.26% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 25.00% | -32.10% | 0.00% | 0.00% | -33.33% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -9.09% | -9.30% | -9.91% | -10.35% | -11.47% |
| Other Financing Activities | -53.61% | -108.00% | -69.89% | -10.34% | 246.43% |
| Cash from Financing | 126.52% | -18.38% | -294.23% | -78.00% | -87.52% |
| Foreign Exchange rate Adjustments | 393.41% | -100.00% | 546.43% | -162.07% | -10.98% |
| Miscellaneous Cash Flow Adjustments | -- | -200.00% | -100.00% | -- | -- |
| Net Change in Cash | 243.92% | -77.50% | -163.24% | -166.72% | -822.05% |